Concord Biotech Limited (CONCORDBIO.NS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Concord Biotech Limited, with annual and quarterly history.
| Metric | 2026 |
|---|---|
| Valuation | |
| P/E Ratio | 41.10x |
| P/B Ratio | 5.32x |
| P/S Ratio | 10.16x |
| Profitability | |
| Gross Margin | 41.9% |
| Operating Margin | 27.8% |
| Net Margin | 24.7% |
| EBITDA Margin | 39.8% |
| Liquidity | |
| Current Ratio | 7.39x |
| Quick Ratio | 5.46x |
| Leverage | |
| Debt/Equity | 0.00x |
YoY = year-over-year change. Source: FMP..